Skip to main content

Daniel Beckerman

Articles From This Author

Valeant Isn't Out of Trouble Yet, Debt Remains Difficult to Curb
OPINION
VRX

Valeant Pharmaceuticals' growth and debt are under the microscope

By Daniel Beckerman
May 11, 2016 2:17 PM EDT
Wall Street Faces a Make-or-Break Week Ahead
OPINION
AAPLMETAGOOG

Surprise! Growth Stocks May Be Better Than Value Stocks When Looking for Value

By Daniel Beckerman
Apr 10, 2015 3:32 PM EDT